5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.04▼ | 1.06▼ | 1.06▼ | 1.14▼ | 1.03▼ |
MA10 | 1.06▼ | 1.08▼ | 1.09▼ | 1.11▼ | 0.99▲ |
MA20 | 1.07▼ | 1.12▼ | 1.12▼ | 1.07▼ | 1.25▼ |
MA50 | 1.11▼ | 1.16▼ | 1.14▼ | 1.00▲ | 2.17▼ |
MA100 | 1.15▼ | 1.13▼ | 1.09▼ | 1.30▼ | 3.53▼ |
MA200 | 1.15▼ | 1.06▼ | 1.02▲ | 1.94▼ | 15.02▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.009▼ | -0.012▼ | 0.004▲ | 0.040▲ |
RSI | 13.904▼ | 23.563▼ | 30.425▼ | 46.626▼ | 39.007▼ |
STOCH | 0.000▼ | 2.115▼ | 0.833▼ | 53.611 | 49.107 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -89.286▼ | -74.026 |
CCI | -106.944▼ | -128.425▼ | -126.019▼ | -59.681 | 9.942 |
Thursday, June 12, 2025 02:00 AM
ATLANTA, GA - June 12, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced that ...
|
Wednesday, June 11, 2025 01:00 AM
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today issued a statement in response to the World Health Organization’s ...
|
Monday, June 09, 2025 06:00 AM
Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron XBB.1.5, Driven by T-Cell Responses ATLANTA, GA - June 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.11 | 1.123 | 1.03 | 1.03 | 209,600 |
12/06/25 | 1.13 | 1.185 | 1.10 | 1.14 | 332,800 |
11/06/25 | 1.24 | 1.2435 | 1.13 | 1.14 | 477,915 |
10/06/25 | 1.27 | 1.27 | 1.20 | 1.22 | 635,165 |
09/06/25 | 1.12 | 1.28 | 1.12 | 1.18 | 1,315,672 |
06/06/25 | 1.12 | 1.1392 | 1.09 | 1.12 | 279,037 |
05/06/25 | 1.11 | 1.14 | 1.07 | 1.09 | 408,733 |
04/06/25 | 1.07 | 1.12 | 1.05 | 1.12 | 299,009 |
03/06/25 | 1.03 | 1.08 | 1.0201 | 1.05 | 272,909 |
02/06/25 | 1.05 | 1.07 | 1.00 | 1.04 | 401,741 |
|
|
||||
|
|
||||
|
|